Liquid chromatography–mass spectrometry (LC–MS) was used to determine if there is a link between artificial sweeteners and breast cancer.
|Articles|November 16, 2021
GC mass spectrometer
The Thermo Scientific Orbitrap Exploris GC-MS is designed to provide high-resolution analysis for everyday testing in a compact instrument that offers sensitivity and mass resolving power up to 60,000. According to the company, the system can provide accurate quantitation and detection of chemical components at trace and high concentrations, for targeted and non-targeted applications.
Thermo Fisher Scientific
San Jose, CA
Related to this article
Chiral gas chromatography–mass spectrometry (GC–MS) shows how heat and storage alter linalool in blueberry juice.
Anneli Kruve reports that toxicity predictions from MS2-derived molecular fingerprints outperform spectral-similarity methods in nontarget screening of food.
In this fourth part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC International’s "Perspectives in HPLC" column editor explains why buffers are most often used in Mobile Phase A in high-pressure liquid chromatography of pharmaceuticals.
Skipping solid-phase extraction (SPE) cleanup rarely hurt liquid chromatography–tandem mass spectrometry (LC–MS/MS) plant hormone results in tomato.
The panel considers how AI and automation could reshape peptide method development, and why scientific judgment will remain essential.
Gas chromatography–mass spectrometry (GC–MS) and docking reveal A. excelsa leaf compounds that may help in cancer treatment.
Gert Desmet offers his insights on the potential benefits AI/ML could offer the separation science community in the future.
Trending on LCGC International
1
LC–MS Probes Link Between Artificial Sweeteners and Breast Cancer
2
AI ML Now: Gert Desmet on the State of Artificial Intelligence and Machine Learning in Separation Science
3
Prioritizing Unknowns in Nontarget Screening of Food Samples
4
Conversations with Michael Dong: Buffers for Mobile Phase A in Pharmaceutical Analysis
5